Haybury

27/09/2023

🌊🌞 Beach Clean Day in Brighton 🌞🌊

Yesterday, we had the incredible opportunity to volunteer and take part in a Brighton seafront beach clean organised by the Marine Conservation Society! 🏖️ This fantastic initiative happens all over the country, bringing communities together to make our beloved beaches cleaner and safer for everyone🌍♻️

We managed to collect 10kg of waste from the beach, which ranged from plastic fragments to bottle caps, glass shards, and even bits of metal. We carefully recorded all the collected waste in order for the Marine Conservation Society to be able to accurately report on it.

A wonderful way for the team to give back to the planet, thank you Marine Conservation Society and thank you also to Aldi for funding this clean.

24/08/2023

🏐SOCIAL DAYS – VOLLEYBALL 🏐

Some of the Haybury team headed down to Yellowave on Brighton beach for a post-work volleyball session.

Summer finally decided to make an appearance for us, so it was a glorious evening spent in the sunshine ☀️

19/06/2023

🏳️‍🌈 HAYBURY SOCIALS - PRIDE BBQ 🏳️‍🌈

To celebrate Pride Month we hosted a pride BBQ on our gorgeous roof terrace in the summer sun ☀️

At Haybury we are proud to stand with the LGBTQ+ community, not just for Pride Month, but all year round.

This and every day, join and work for a more inclusive 🌏 for all.

+

25/03/2022

🐶 HAYBURY SOCIAL DAYS | DOG WALK 🐶

As part of our social schedule, some of our Haybury team went on a sunny morning walk with a few of our Haybury dogs.

A great way to start your day soaking up that vitamin D, catching up with colleagues and spending time with our furry friends.

08/03/2022

👩‍💻 International Women’s Day 2022👩‍💻

At Haybury we pride our ourselves on creating diverse and inclusive environments for all.

Our team includes these inspiring women who support our clients and candidates across the world in delivering life changing innovations across the Pharma and Life Sciences sector.

👏Today and every day we celebrate our female team members and leaders that make the Haybury team truly remarkable.

22/01/2022

Eleusis joins cooled-off S**C market with $288M to bankroll psychedelic-based depression drug https://bit.ly/3fQFFKJ

With investor interest in psychedelics heating up, Eleusis joins the relatively quiet S**C market in a deal that gives the biotech $288 million to test a psilocybin-based treatment for depression. The proceeds will also bankroll an expansion of subsidiary Andala's drug therapy clinics.

21/01/2022

Fierce JPM Week: Women are the 'power buyers' of healthcare. Here's how startups are striving to serve them https://bit.ly/33XbPlm &Hers

Women's health is now in the spotlight, and investors have been quick to put their cash into this growing market. What's next for women's health? Three executives—Hilary Coles, co-founder of Hims & Hers, Carolyn Witte, co-founder of Tia and Lynne Chou O'Keefe from Define Ventures—share their per...

17/01/2022

Fending off heart disease by blocking how immune cells 'smell' their surroundings https://bit.ly/3IcUIdU

Scientists at La Jolla Institute for Immunology have discovered that macrophages in arteries could "smell" its surroundings to trigger inflammation in atherosclerosis. Blocking a key protein receptor involved in the process could be a promising target for treating cardiovascular disease, they said.

17/01/2022

Idorsia makes friends with Jen Aniston for new sleep campaign, as it preps for insomnia drug launch https://bit.ly/3txrjHn

The average person doesn’t have a lot in common with Jennifer Aniston—her fame, her money, her looks (that hair!) However, there is one thing 25 million Americans do share with the A-lister—insomnia.

12/01/2022

South Korea's SK commits $350M to help build global cell and gene therapy CDMO https://bit.ly/3FeuXZ3

South Korea’s SK Inc. committed $350 million in equity financing to the Center for Breakthrough Medicines as part of the partnership the organizations unveiled two months ago in their effort to build a global end-to-end cell and gene therapy CDMO.

12/01/2022

Revivicor's genetically modified pig heart is first successfully transplanted in human patient https://bit.ly/3tiS8ip

Once as improbable an idea as seeing pigs fly, the xenotransplantation of organs from animals to humans is becoming an increasingly viable option as the science of genetic editing improves and organ donor waitlists lengthen.